To determine the ability of pimozide to inhibit STAT5 activation in PTCL, we cultured HuT102 and Kit225 cells in a range of drug concentrations for 48h [38, 39]. The gene discussed is STAT5A; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.